Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin

NCT01006603 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

957

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Saxagliptin
DRUG: Glimepiride

Sponsor

AstraZeneca

Collaborators

[object Object]